FibroGen Soars 26% In 5 Sessions: Is It Time To Buy?
(VIANEWS) – FibroGen shares have shown significant gains, outpacing those seen at NASDAQ in just five sessions. FibroGen (NASDAQ: FGEN) shares have experienced an exceptional surge over the past five sessions, increasing 26.97% from EUR0.46 to EUR0.58, thanks to an overall market uptick. The NASDAQ index rose 0.25% and now stands at EUR14,220.81. FibroGen’s stock…